1 Product identity
Ingredient risk
Contains restricted ingredients
აშვაგანდა 60 კაფსულა ფიური - Pure
BrandPure→Dietary Supplement 1 ingredients 1 banned Source: psp.ge ↗DSLD entry: 2026-06-02
2 Ingredients (1)
IngredientGroupSafety
Ingredient details from the manufacturer listing. View product at psp.ge →
⛔ Contains an ingredient banned in ≥1 country
Ashwagandha 🇩🇰 🇧🇪 🇪🇺 — Banned April 2023 following DTU risk assessment. All products withdrawn.
3 Safety cross-reference
Ashwagandha — Banned in ≥1 country
⚠ Thyroid stimulation
⚠ HEPATOTOXICITY (rare but serious case reports)
5 Data source
DSLD ID900000113
Full labelView at NIH DSLD →
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2026-06-02
6 More from Pure
View Pure Safety Scorecard → 21 products
B კომპლექსი პლუსი 60 კაფსულა ფიური - PureBCAADHEA 25მგ 60 კაფსულა ფიური - PureEPA-DHA 90 კაფსულა ფიური - PureGABA 60 კაფსულა ფიური - PureNაცეტილ Lცისტეინ 600 30 კაფსულა ფიური - Pure7 Cite this page
Vancouver
Pkhakadze G. აშვაგანდა 60 კაფსულა ფიური - Pure — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 28]. Available from: https://supplement.ge/products/dsld-900000113/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
Publisher: PHIG